| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.013 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |